|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
2
|
Zenith Epigenetics
|
Apr 14, 2022 10:31AM
|
|
SEDI Insider filing
|
1
|
Resverlogix Corp.
|
Apr 13, 2022 12:43PM
|
|
Re: Seems to be some interest
|
4
|
Resverlogix Corp.
|
Apr 13, 2022 10:27AM
|
|
Re: Seems to be some interest
|
4
|
Resverlogix Corp.
|
Apr 13, 2022 09:43AM
|
|
COVID 19 / varients
|
2
|
Resverlogix Corp.
|
Apr 10, 2022 03:15PM
|
|
AGM-Resverlogix
|
3
|
Resverlogix Corp.
|
Apr 08, 2022 05:03PM
|
|
Re: Debt
|
3
|
Zenith Epigenetics
|
Apr 06, 2022 11:38AM
|
|
Re: Debt
|
2
|
Zenith Epigenetics
|
Apr 06, 2022 10:29AM
|
|
Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
2
|
Resverlogix Corp.
|
Apr 06, 2022 06:57AM
|
|
Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
1
|
Resverlogix Corp.
|
Apr 05, 2022 07:22PM
|
|
Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
1
|
Resverlogix Corp.
|
Apr 05, 2022 05:52PM
|
|
Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
9
|
Resverlogix Corp.
|
Apr 05, 2022 12:51PM
|
|
FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
5
|
Resverlogix Corp.
|
Apr 05, 2022 10:37AM
|
|
Re: Debt
|
2
|
Zenith Epigenetics
|
Apr 04, 2022 10:39AM
|
|
Re: Debt
|
2
|
Zenith Epigenetics
|
Apr 04, 2022 09:48AM
|
|
Re: Debt
|
1
|
Zenith Epigenetics
|
Apr 03, 2022 04:30PM
|
|
Re: Debt
|
4
|
Zenith Epigenetics
|
Apr 03, 2022 04:08PM
|
|
Re: Debt
|
2
|
Zenith Epigenetics
|
Apr 03, 2022 01:04PM
|
|
Re: Self Financing
|
2
|
Resverlogix Corp.
|
Apr 02, 2022 07:06AM
|
|
Re: RVX- Exempt Distribution
|
1
|
Resverlogix Corp.
|
Apr 01, 2022 11:25AM
|
